These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2004-004286-15 A Phase II, Multi-Center, Open-Label, Repeat-Dose Study of Forodesine Hydrochloride (BCX-1777) Infusion in Patients with Advanced T-Cell Leukemia with an Option of Long-Term Forodesine Hydrochloride (... 2007-03-27 bad-data
Exempt 2005-000627-42 A Phase I/II, Multi-Center, Open-Label, Repeat-Dose Study of Forodesine Hydrochloride Infusion in Patients with B-cell Acute Lymphoblastic Leukemia with an Option of Extended Use of Forodesine Hydroch... 2007-03-27 not-yet-due
Ongoing 2006-005196-17 A phase II, Multicenter, Randomised, Double-Mask, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects with Uncomplicated Acute Influenza not-yet-due
Listed as ongoing, but also has a completion date 2007-002093-60 Ensayo de agente único en fase II sobre la forodesina (BCX1777) en el tratamiento del linfoma cutáneo de células T 2011-12-07 bad-data
Listed as ongoing, but also has a completion date 2007-002527-32 A Phase II/III, Multicenter, Ramdomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects with Uncomplicated Acute Influenza 2008-01-23 bad-data
Not reported Terminated 2007-004660-47 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Virologic Activity, Safety, and Pharmacodynamics of Intravenous Peramivir for the Treatment of Experimental Influenza 2008-08-28 due-trials
Listed as ongoing, but also has a completion date 2009-012367-34 A Phase 3, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of Peramivir Administered Intravenously in Addition to Standard of Care Compared to Standard of C... 2012-11-08 bad-data
Not reported 2013-002319-82 A Phase 2a double-blind placebo-controlled 2-period crossover study to evaluate the safety and efficacy of BCX4161 as a prophylactic treatment to reduce the frequency of attacks in subjects with hered... 2014-05-13 due-trials
Listed as ongoing, but also has a completion date 2014-002655-26 OPuS-2: A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two dose levels of BCX4161 for 12 weeks as an oral prophylaxis treatmen... 2016-01-08 bad-data
Not reported 2015-003242-22 OPuS-4: An open-label study to evaluate the long-term safety of avoralstat in subjects with hereditary angioedema 2016-02-26 due-trials
Listed as ongoing, but also has a completion date 2015-003923-74 A randomized, double-blind, 4 week, placebo-controlled, dose-ranging, parallel-group study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BCX7353 as a preven... 2016-03-29 bad-data
Listed as ongoing, but also has a completion date 2016-001272-29 A randomized, double-blind, placebo-controlled, dose-ranging, parallel-group study to evaluate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of BCX7353 as a preventative tr... 2017-08-08 bad-data
Listed as ongoing, but also has a completion date 2016-001424-55 A randomized, double-blind, placebo-controlled, dose-ranging, study to evaluate the efficacy, safety and tolerability of single doses of BCX7353 as an acute attack treatment in subjects with hereditar... 2019-01-03 bad-data
Ongoing 2017-003281-27 An Open-Label study to Evaluate the Long-Term Safety of Daily Oral BCX7353 in subjects with Type I and II Hereditary Angioedema not-yet-due
Listed as ongoing, but also has a completion date 2017-003966-29 A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two dose levels of BCX7353 as an oral treatment for the prevention of attacks in su... 2018-10-24 bad-data